Successful treatment of osteolytic epithelioid hemangioendothelioma with pamidronate.
We describe the case of a 70-year-old man with unicentric grade 1 epitheloid hemangioendothelioma (EH) of the bone that favourably responded to intravenous pamidronate as a single agent. After 6 years of follow-up, the patient was in complete remisssion. We suggest that use of bisphosphonates should be considered in the treatment of osteolytic EH.